drugset / Trial / NCT01529177

Metformin for the Treatment of Unexplained Oligozspermia

NCT01529177

Phase 4 Unknown 600 enrolled The Egyptian IVF-ET Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Insulin resistance (IR) in men may be the underlying pathogenesis for metabolic abnormalities and chronic hypospermatogenesis similar to women with polycystic ovarian disease (PCOD). Infertile men with unexplained infertility and IR may benefit from treatment with metformin.

Timeline

Start
2012-02
Primary completion
2016-09
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 50 mg Oral
Subject Metformin Small molecule 1000 mg Oral
Subject human chorionic gonadotropin Protein / enzyme biologic 5000 iu Intramuscular

Indications